THE CHEMOKINE FRACTALKINE (CX3CL1) HAS ANTI-APOPTOTIC AND PROLIFERATIVE EFFECTS ON PRIMARY HUMAN SMOOTH MUSCLE CELLS VIA EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALLING

THE CHEMOKINE FRACTALKINE (CX3CL1) HAS ANTI-APOPTOTIC AND PROLIFERATIVE EFFECTS ON PRIMARY HUMAN SMOOTH MUSCLE CELLS VIA EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALLING

Bibliographic Details
Main Authors:	White, G, Greaves, D
Format:	Conference item
Published:	2009

Similar Items

Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.
by: White, G, et al.
Published: (2010)

Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
by: Lucas, A, et al.
Published: (2003)

The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.
by: Lucas, A, et al.
Published: (2001)

The CX3C chemokine fractalkine acts via an extracellular regulated kinase-dependent mechanism to induce human coronary artery smooth muscle cell proliferation
by: White, G, et al.
Published: (2007)

Fractalkine: one chemokine, many functions.
by: White, G, et al.
Published: (2009)

Fractalkine/CX3CL1 in Neoplastic Processes
by: Jan Korbecki, et al.
Published: (2020-05-01)

Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators.
by: White, G, et al.
Published: (2012)

Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation.
by: Clotilde eLauro, et al.
Published: (2015-01-01)

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).
by: Garton, K, et al.
Published: (2001)

Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
by: CHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng
Published: (2023-12-01)

Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα
by: Sabine Rutti, et al.
Published: (2014-10-01)

Fractalkine Signalling (CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 Axis) as an Emerging Target in Coronary Artery Disease
by: Shu Xian Loh, et al.
Published: (2023-07-01)

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients
by: Valentina Marchica, et al.
Published: (2019-03-01)

Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions.
by: Greaves, D, et al.
Published: (2001)

Chemokine Fractalkine and Non-Obstructive Coronary Artery Disease—Is There a Link?
by: Aleksandra Stangret, et al.
Published: (2024-03-01)

Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
by: N. P. Camacho-Hernández, et al.
Published: (2023-01-01)

Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8+ T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients
by: Melissa J. Conroy, et al.
Published: (2018-08-01)

The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.
by: Johnson, L, et al.
Published: (2013)

Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus
by: Amin Ullah, et al.
Published: (2023-10-01)

Chemokines, chemokine receptors and atherosclerosis
by: John, A, et al.
Published: (2005)

The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
by: Masaaki Fujita, et al.
Published: (2014-01-01)

CX Chemokine Receptor 7 Contributes to Survival of <i>KRAS</i>-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor
by: Bin Liu, et al.
Published: (2019-03-01)

Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
by: Liao Jun, et al.
Published: (2023-12-01)

Triptolide alleviates cerebral ischemia/reperfusion injury via regulating the Fractalkine/CX3CR1 signaling pathway
by: Jiajun Zhou, et al.
Published: (2024-06-01)

Fractalkine/CX<sub>3</sub>CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?
by: Visvesh Jeyalan, et al.
Published: (2023-09-01)

Relative expression of hormone receptors by endothelial and smooth muscle cells in proliferative and non-proliferative areas of congenital arteriovenous malformations
by: A. M. Utami, et al.
Published: (2023-10-01)

Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
by: White, G, et al.
Published: (2014)

A new class of membrane-bound chemokine with a CX3C motif.
by: Bazan, J, et al.
Published: (1997)

Serum Levels and in vitro CX3CL1 (Fractalkine), CXCL8, and IL-10 Synthesis in Phytohemaglutinin-Stimulated and Non-stimulated Peripheral Blood Mononuclear Cells in Subjects With Schizophrenia
by: Jaśmina Arabska, et al.
Published: (2022-06-01)

The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
by: Apoorvi Chaudhri, et al.
Published: (2023-09-01)

CX3CL1(+) Microparticles-Induced MFG-E8 Enhances Apoptotic Cell Clearance by Alveolar Macrophages
by: Wen-Hui Tsai, et al.
Published: (2021-09-01)

808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy
by: Patrick Hwu, et al.
Published: (2023-11-01)

CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.
by: White, G, et al.
Published: (2013)

The chemokine receptor CX3CR1 coordinates monocyte recruitment and endothelial regeneration after arterial injury
by: Tobias Getzin, et al.
Published: (2018-02-01)

Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1I249/M280 Variant
by: Sandra M. Cardona, et al.
Published: (2018-10-01)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
by: Paulina Pawelec, et al.
Published: (2020-10-01)

The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide
by: Mark M. Perry, et al.
Published: (2018-05-01)

CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer
by: Xiangyang Liu, et al.
Published: (2024-04-01)

FRACTALKINE: PATHOGENIC ROLE AND DIAGNOSTIC CAPABILITIES
by: O. A. MESNYANKINA, et al.
Published: (2017-06-01)

Correction: Fractalkine Depresses Cardiomyocyte Contractility
Published: (2013-01-01)